Platforms for manufacturing allogeneic, autologous and iPSC cell therapy products: an industry perspective

E Abraham, BB Ahmadian, K Holderness… - … and manufacturing of …, 2018 - Springer
As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …
被引用次数：38 相关文章

Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective

E Abraham, BB Ahmadian, K Holderness… - Adv Biochem Eng …, 2018 - Springer
As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …

Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective.

E Abraham, BB Ahmadian, K Holderness… - Advances in …, 2018 - europepmc.org
As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …

Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective

E Abraham, BB Ahmadian… - Advances in …, 2018 - pubmed.ncbi.nlm.nih.gov
As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …

Platforms for Manufacturing Allogeneic, Autologous and iPSC Cell Therapy Products: An Industry Perspective

E Abraham, BB Ahmadian, K Holderness… - … and Manufacturing of …, 2018 - books.google.com
As cell therapy processes mature from benchtop research protocols to industrial processes
capable of manufacturing market-relevant numbers of doses, new cell manufacturing …